AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
MONTELUKAST SODIUM in Zimbabwe
9 products registered with MCAZ β 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MONAST 10 TABLET; ORAL | 2016/22.1.1/5148 | HETERO LABS LTD | active | 12 Feb 2030 |
| BREATHEZY TABLET; ORAL | 2015/21.1.1/5032 | MSN LABORATORIES LTD | active | 2 Sept 2029 |
| BREATHEZY CW 5 TABLET; ORAL | 2015/21.1.1/5031 | MSN LABORATORIES LTD | active | 2 Sept 2029 |
| MONTERA 10 TABLET, COATED; ORAL | 2015/22.1.1/5041 | COSPHARM INVESTMENTS PVT LIMITED | active | 31 Dec 2027 |
| ASTHATOR 5 TABLET; ORAL | 2015/22.1.1/5127 | TORRENT EXPORTS LTD | active | 31 Dec 2027 |
| MONTEMAC 10 TABLET, COATED; ORAL | 2026/22.1.1/7324 | MACLEODS PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
| ASTHATORIO TABLET; ORAL | 2015/22.1.1/5126 | TORRENT EXPORTS LTD | active | 31 Dec 2027 |
| MONTERA 4 TABLET; ORAL | 2015/22.1.1/5039 | COSPHARM INVESTMENTS PVT LIMITED | active | 31 Dec 2027 |
| MONTERA 5 TABLET, COATED; ORAL | 2015/22.1.1/5040 | COSPHARM INVESTMENTS PVT LIMITED | active | 31 Dec 2027 |
MONTELUKAST SODIUM β MCAZ Registration Details
MCAZ (Zimbabwe) has 9 registered products containing MONTELUKAST SODIUM, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track MONTELUKAST SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.